| Filed On | Filing |
|---|---|
| 24 Feb 2022 |
Form 3: Tursi James Patrick, Executive VP, Global R&D
Holds 280,373 shares of 2015 Stock Incentive Plan Restricted Stock Units (RSU) |
| 09 Aug 2021 |
Form 3: Raciti Frank B., VP, Controller and CAO
Holds 6,152 shares of Ordinary Shares |
| 17 Feb 2021 |
Form 3: Chao Jennifer M, Director
Holds 0 shares of No securities beneficially owned |
| 12 Nov 2020 |
Form 3: Apostol George, EVP, Head of Global R&D
Holds 45,811 shares of 2015 Stock Incentive Plan Restricted Stock Units (RSU) |
| 29 Oct 2020 |
Form 3: Endo International plc, See footnotes (1)(2)(3)(4) · BIOSPECIFICS TECHNOLOGIES CORP
Holds 0 shares of Common Stock, $0.001 par value |
| 29 Jul 2020 |
Form 3: Smith Mary Christine, Director
Holds 0 shares of No securities beneficially owned |
| 06 Mar 2020 |
Form 3: Bradley Mark T., EVP, Chief Financial Officer
Holds 11,887 shares of Ordinary Shares |
| 28 Feb 2020 |
Form 3: Barberio Mark G, Director
Holds 0 shares of No securities beneficially owned |
| 03 Oct 2019 |
Form 3: Boyle Jack D., SVP, Interim Controller
Holds 16,239 shares of Ordinary Shares |
| 09 Aug 2019 |
Form 3: Garella Rahul, EVP, Intl Pharmaceuticals
Holds 24,116 shares of Ordinary Shares |
| 09 Aug 2019 |
Form 3: Ciarico Domenico, EVP & Chief Commercial Officer
Holds 10,744 shares of Ordinary Shares |
| 03 Apr 2018 |
Form 3: Nichol Carrie Ann, VP, Controller & CAO
Holds 3,286 shares of Ordinary Shares |
| 06 Mar 2018 |
Form 3: Barry Patrick A, EVP & Chief Commercial Officer
Holds 3,180 shares of Ordinary Shares |
| 13 Nov 2017 |
Form 3: Mansukani Sharad, Director
Holds 23,793 shares of Ordinary Shares |
| 22 Nov 2016 |
Form 3: Coleman Blaise, SVP Glob Finance & Interim CFO
Holds 3,153 shares of Ordinary Shares |
| 08 Nov 2016 |
Form 3: Pera Antonio R, President, Par Pharmaceutical
Holds 19,022 shares of Ordinary Shares |
| 08 Nov 2016 |
Form 3: Coughlin Terrance J, EVP & Chief Operating Officer
Holds 119,837 shares of Ordinary Shares |
| 18 Aug 2016 |
Form 3: Ciaffoni Joseph, President, U.S. Branded Pharma
Holds 0 shares of No securities beneficially owned |
| 09 May 2016 |
Form 3: Ingram Douglas S, Director
Holds 0 shares of No securities beneficially owned |
| 05 May 2016 |
Form 3: Sisitsky Todd Benjamin, Director
Holds 0 shares of No securities beneficially owned |
Loading...